N@N

Paul Choi Initiated (ASND) at Strong Buy and Held Target at $174 on, Oct 20th, 2022

Paul Choi of Goldman Sachs, Initiated "Ascendis Pharma A/S" (ASND) at Strong Buy and Held Target at $174 on, Oct 20th, 2022.

Paul has made no other calls on ASND in the last 4 months.

There are 5 other peers that have a rating on ASND. Out of the 5 peers that are also analyzing ASND, 0 agree with Paul's Rating of Hold.

These are the ratings of the 5 analyists that currently disagree with Paul

---

• Derek Archila of "Wells Fargo" Maintained at Buy with Increased Target to $172 on, Thursday, September 22nd, 2022
• Caroline Palomeque of "Berenberg" Initiated at Strong Buy and Held Target at $166 on, Tuesday, August 30th, 2022
• Joseph Schwartz of "SVB Leerink" Maintained at Buy with Decreased Target to $168 on, Thursday, August 11th, 2022
• Leland Gershell of "Oppenheimer" Maintained at Buy with Decreased Target to $144 on, Thursday, August 11th, 2022
• Vikram Purohit of "Morgan Stanley" Maintained at Buy with Decreased Target to $148 on, Thursday, August 11th, 2022

Contributing Sources

---